enParticle Co.
Latest round
- Series A
Last raised
- Nov 2024
Total raised
- $3.2M
Investors
- 3
About enParticle Co.
, Ltd. specialises in advanced microfluidic technologies for drug delivery systems for pharmaceutical and cosmetic formulations. enParticle offers advanced microfluidic technologies for the formulation and mass production of drug delivery systems (DDS) for pharmaceuticals and cosmetics. The primary product offerings include enCELL Master, enCELL Pharm, and enCELL Scale-Up, microfluidic formulation machines to produce lipid nanoparticles (LNPs), liposomes, and polymeric vesicles, which are critical in the development of innovative pharmaceuticals and cosmetic formulations. The enCell device facilitates the production of mRNA vaccines by ensuring uniformity and yields in particle size and chemical homogeneity. The company provides contract development and manufacturing services to assist pharmaceutical companies in accelerating development timelines. These products primarily serve pharmaceutical companies, biotechnology firms, and cosmetic manufacturers in markets such as North America, Europe, and Asia.
Who invested in enParticle Co.
3 investors across 1 round
See all investors in enParticle Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 25, 2024
Amount
$3.2M
Investors
Questions about enParticle Co.
Who invested in enParticle Co.?
enParticle Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has enParticle Co. raised?
enParticle Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did enParticle Co. last raise money?
enParticle Co.'s most recent round on record is a Series A, in Nov 2024.
What does enParticle Co. do?
enParticle Co. is a biotechnology company.
Where is enParticle Co. headquartered?
enParticle Co. is headquartered in Busan, South Korea.
Which VCs invest in companies like enParticle Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at enParticle Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like enParticle Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.